Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals

We analyzed 221 coronavirus disease 2019 cases identified between June 2020 and January 2021 in 6074 individuals screened for immunoglobulin G antibodies in May 2020, representing 77% of residents of 5 Italian municipalities. The relative risk of developing symptomatic infection in seropositive part...

Descripción completa

Detalles Bibliográficos
Autores principales: Manica, Mattia, Pancheri, Serena, Poletti, Piero, Giovanazzi, Giulia, Guzzetta, Giorgio, Trentini, Filippo, Marziano, Valentina, Ajelli, Marco, Grazia Zuccali, Maria, Benetollo, Pier Paolo, Merler, Stefano, Ferro, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406865/
https://www.ncbi.nlm.nih.gov/pubmed/34134145
http://dx.doi.org/10.1093/cid/ciab556
_version_ 1783746566772752384
author Manica, Mattia
Pancheri, Serena
Poletti, Piero
Giovanazzi, Giulia
Guzzetta, Giorgio
Trentini, Filippo
Marziano, Valentina
Ajelli, Marco
Grazia Zuccali, Maria
Benetollo, Pier Paolo
Merler, Stefano
Ferro, Antonio
author_facet Manica, Mattia
Pancheri, Serena
Poletti, Piero
Giovanazzi, Giulia
Guzzetta, Giorgio
Trentini, Filippo
Marziano, Valentina
Ajelli, Marco
Grazia Zuccali, Maria
Benetollo, Pier Paolo
Merler, Stefano
Ferro, Antonio
author_sort Manica, Mattia
collection PubMed
description We analyzed 221 coronavirus disease 2019 cases identified between June 2020 and January 2021 in 6074 individuals screened for immunoglobulin G antibodies in May 2020, representing 77% of residents of 5 Italian municipalities. The relative risk of developing symptomatic infection in seropositive participants was 0.055 (95% confidence interval, .014–.220).
format Online
Article
Text
id pubmed-8406865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84068652021-09-01 Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals Manica, Mattia Pancheri, Serena Poletti, Piero Giovanazzi, Giulia Guzzetta, Giorgio Trentini, Filippo Marziano, Valentina Ajelli, Marco Grazia Zuccali, Maria Benetollo, Pier Paolo Merler, Stefano Ferro, Antonio Clin Infect Dis Brief Reports We analyzed 221 coronavirus disease 2019 cases identified between June 2020 and January 2021 in 6074 individuals screened for immunoglobulin G antibodies in May 2020, representing 77% of residents of 5 Italian municipalities. The relative risk of developing symptomatic infection in seropositive participants was 0.055 (95% confidence interval, .014–.220). Oxford University Press 2021-06-16 /pmc/articles/PMC8406865/ /pubmed/34134145 http://dx.doi.org/10.1093/cid/ciab556 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Manica, Mattia
Pancheri, Serena
Poletti, Piero
Giovanazzi, Giulia
Guzzetta, Giorgio
Trentini, Filippo
Marziano, Valentina
Ajelli, Marco
Grazia Zuccali, Maria
Benetollo, Pier Paolo
Merler, Stefano
Ferro, Antonio
Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title_full Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title_fullStr Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title_full_unstemmed Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title_short Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
title_sort risk of symptomatic infection during a second coronavirus disease 2019 wave in severe acute respiratory syndrome coronavirus 2–seropositive individuals
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406865/
https://www.ncbi.nlm.nih.gov/pubmed/34134145
http://dx.doi.org/10.1093/cid/ciab556
work_keys_str_mv AT manicamattia riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT pancheriserena riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT polettipiero riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT giovanazzigiulia riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT guzzettagiorgio riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT trentinifilippo riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT marzianovalentina riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT ajellimarco riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT graziazuccalimaria riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT benetollopierpaolo riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT merlerstefano riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals
AT ferroantonio riskofsymptomaticinfectionduringasecondcoronavirusdisease2019waveinsevereacuterespiratorysyndromecoronavirus2seropositiveindividuals

Ejemplares similares